Trial
NCT06005792
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Xencor, Inc.
Collaborators
—
Condition
Psoriasis
Intervention
XmAb27564
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-02